Charles Schwab Investment Management »

Conduit Pharmaceuticals shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDT) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.3k 53k 0.12
2024-06-30 $56k 53k 1.06

More positions owned by Charles Schwab Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us S (FNDA)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Broadcom (AVGO)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Schwab Strategic Tr Fundamental Intl (FNDF)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Charles Schwab Investment Management

Top funds holding Conduit Pharmaceuticals

Barclays
BlackRock
BlackRock
Geode Capital Management
Vanguard Group
Citadel Advisors
Northern Trust
New York State Common Retirement Fund
State Street Corporation
Morgan Stanley
Charles Schwab Investment Management
Bridgeway Capital Management
JustInvest
SG Americas Securities
AQR Capital Management

View all funds holding Conduit Pharmaceuticals